We are live on ! Find out more
TECH icon

Bio-Techne

262 hedge funds and large institutions have $3.33B invested in Bio-Techne in 2014 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 82 increasing their positions, 87 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 27

6% more funds holding

Funds holding: 248262 (+14)

1% less capital invested

Capital invested by funds: $3.38B → $3.33B (-$48.9M)

6% less repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 87

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $231K

Holders
262
Holders Change
+14
Holders Change %
+5.65%
% of All Funds
6.99%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
45
Increased
82
Reduced
87
Closed
27
Calls
Puts
$231K
Net Calls
-$231K
Net Calls Change
-$44K
Name Holding Trade Value Shares
Change
Change in
Stake
PA
101
Profund Advisors
Maryland
$2.73M +$344K +15,048 +15%
GCP
102
GSA Capital Partners
United Kingdom
$2.71M +$351K +15,324 +15%
TA
103
Teachers Advisors
New York
$2.71M +$176K +7,684 +7%
State of Wisconsin Investment Board
104
State of Wisconsin Investment Board
Wisconsin
$2.67M +$149K +6,520 +6%
Grantham, Mayo, Van Otterloo & Co (GMO)
105
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$2.62M -$974K -42,564 -27%
US Bancorp
106
US Bancorp
Minnesota
$2.62M -$108K -4,700 -4%
OPPM
107
Opus Point Partners Management
New York
$2.58M +$2.55M +111,600 New
AP
108
AHL Partners
United Kingdom
$2.55M +$2.28M +99,420 +910%
TCM
109
Tributary Capital Management
Nebraska
$2.53M +$1.66M +72,400 +195%
UBS Group
110
UBS Group
Switzerland
$2.51M +$2.49M +108,700 New
DekaBank Deutsche Girozentrale
111
DekaBank Deutsche Girozentrale
Germany
$2.47M +$437K +19,100 +22%
GIP
112
Granite Investment Partners
California
$2.35M -$83.3K -3,640 -3%
MOACM
113
Mutual of America Capital Management
New York
$2.16M +$24.3K +1,060 +1%
ASRS
114
Arizona State Retirement System
Arizona
$2.13M -$27.5K -1,200 -1%
Two Sigma Investments
115
Two Sigma Investments
New York
$2.06M +$2.04M +89,052 New
WBC
116
Westpac Banking Corp
Australia
$1.99M
UBS AM
117
UBS AM
Illinois
$1.97M +$45.8K +2,000 +2%
Nisa Investment Advisors
118
Nisa Investment Advisors
Missouri
$1.94M -$18.3K -800 -0.9%
LIM
119
Leavell Investment Management
Alabama
$1.88M
NC
120
Nicholas Company
Wisconsin
$1.86M
JA
121
JLB & Associates
Michigan
$1.81M
RP
122
Rowlandmiller & Partners
Georgia
$1.68M +$1.66M +72,700 New
T. Rowe Price Associates
123
T. Rowe Price Associates
Maryland
$1.67M +$90.4K +3,952 +6%
BG
124
BlackRock Group
United Kingdom
$1.67M +$507K +22,132 +44%
CIM
125
Confluence Investment Management
Missouri
$1.64M -$23K -1,004 -1%

TECH Hedge Fund Activity: Q4 2014 in Review

262 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2014, worth a combined $3.33B — down 1.4% from $3.38B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new TECH positions and 27 closed out — a net gain of 18 holders — while 82 added to existing stakes and 87 trimmed.

The largest buyer was Mairs & Power Inc, adding an estimated $18.8M. The largest seller was Kayne Anderson Rudnick Investment Management, exiting entirely with an estimated $71M sold.

  • 262 institutional investors held Bio-Techne (TECH) as of Q4 2014, up from 248 in Q3 2014.
  • Funds reported $3.33B of Bio-Techne stock for Q4 2014, down 1.4% quarter-over-quarter.
  • 45 funds opened new Bio-Techne positions in Q4 2014 and 27 closed out, a net change of +18 holders.
  • The largest Bio-Techne buyer in Q4 2014 was Mairs & Power Inc, an estimated $18.8M added.
  • The largest Bio-Techne seller in Q4 2014 was Kayne Anderson Rudnick Investment Management, an estimated $71M sold.

Based on aggregated 13F filings for Q4 2014.